Restart Life Sciences Corp. (CSE:HEAL)

Restart Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.01	0.01	0.27	0.22	2.14
Short-Term Investments	0.16	-	-	-	0.01
Cash & Short-Term Investments	0.17	0.01	0.27	0.22	2.14
Cash Growth	2001.30%	-96.97%	21.85%	-89.78%	152.60%
Accounts Receivable	-	-	-	-	0.02
Other Receivables	0.01	0.01	0.01	0.07	-
Receivables	0.01	0.01	0.01	0.07	0.02
Inventory	-	-	-	-	0.01
Prepaid Expenses	-	0	0.01	0.04	0.42
Total Current Assets	0.18	0.02	0.28	0.33	2.58
Property, Plant & Equipment	0.01	0.01	0.01	0.02	0.02
Long-Term Investments	-	-	-	-	0.44
Total Assets	0.19	0.03	0.3	0.88	3.05
Accounts Payable	0.19	0.39	0.12	0.4	0.32
Accrued Expenses	0.21	0.45	0.14	0.02	0.07
Short-Term Debt	0.08	-	-	-	-
Total Current Liabilities	0.49	0.84	0.26	0.42	0.38
Total Liabilities	0.49	0.84	0.26	0.42	0.38
Common Stock	50.52	50.19	50.07	48.37	48.24
Retained Earnings	-59.06	-59.29	-58.06	-55.6	-52.91
Comprehensive Income & Other	8.25	8.29	8.04	7.69	7.34
Shareholders' Equity	-0.3	-0.81	0.04	0.46	2.66
Total Liabilities & Equity	0.19	0.03	0.3	0.88	3.05
Total Debt	0.08	-	-	-	-
Net Cash (Debt)	0.09	0.01	0.27	0.22	2.14
Net Cash Growth	963.58%	-96.97%	21.85%	-89.78%	152.60%
Net Cash Per Share	0.01	0.00	0.02	0.02	0.42
Filing Date Shares Outstanding	33.23	14.82	14.71	14.22	11.11
Total Common Shares Outstanding	18.01	14.72	14.51	11.15	11.11
Working Capital	-0.31	-0.82	0.03	-0.09	2.2
Book Value Per Share	-0.02	-0.06	0.00	0.04	0.24
Tangible Book Value	-0.3	-0.81	0.04	0.46	2.66
Tangible Book Value Per Share	-0.02	-0.06	0.00	0.04	0.24
Machinery	0.06	0.06	0.06	0.06	0.06

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.